Purpose: To perform an age-stratified analysis of the effect of diabetes and pseudophakia on corneal endothelial cell density (ECD).
D
iabetes mellitus has long been known to have an effect on the function and morphology of the corneal endothelium. 1, 2 Numerous direct clinical observations of the diabetic cornea show variations in the endothelial cell microarchitecture. However, there is still no consensus on the effect of diabetes on corneal endothelial cell density (ECD). Several reports show a decreased ECD in patients with diabetes, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] whereas some studies show no difference [14] [15] [16] or even increased ECD. 17 Furthermore, the effect of cataract surgery on the diabetic corneal endothelium is inconclusive, with some reports demonstrating increased vulnerability to surgery [18] [19] [20] [21] and others showing no difference. 22, 23 Although most of these investigations are single-center observational studies, none has yet reported data collected through an eye bank. To investigate the effect of diabetes and pseudophakia on ECD, we queried the large data set available through the eye bank at the Lions Eye Institute in Tampa, Florida.
METHODS
Our study protocol was deemed exempt by the Albert Einstein College of Medicine Institutional Review Board. Corneal donor data and donor tissue characteristics of all consecutive eyes collected from July 1, 2007, to May 23, 2014 , were reported from the Lions Eye Institute in Tampa, Florida.
Information regarding the cornea donor, including age, sex, race, medical history, medication list, and cause of death, was obtained from medical records, health care provider interviews, and family members. The diabetic status was determined by matching terms for diabetes in the medical history and querying for antihyperglycemic medications in the medication list. Further medical details, such as distinction between type 1 versus type 2 diabetes, duration of disease, hemoglobin A1c, and the presence and severity of concomitant diabetic retinopathy, were not recorded as part of routine medical records collection by the eye bank and were thus unavailable for analysis.
ECD was obtained using a specular microscope (Konan EB-10; Konan, Hyogo, Japan). The image quality was graded using a 5-step rubric that defined endothelial morphology and image quality. A final ECD reading was obtained after technicians manually identified 3 to 5 micrographs with a minimum of 100 cell centers. Eye bank technicians were trained and certified in-house with periodic examinations to maintain standardization of readings between individuals. The phakic status was ascertained by a technician at the time of harvest. Data regarding pachymetry, endothelial cell polymorphism, and polymegathism were not included in this database for analysis.
Both suitable and unsuitable donor tissues were included in the analysis for ECD as this study sought to address the overall effect of diabetes on the cornea. Corneas that were deemed unsuitable were either destroyed or designated for research. The 3 most commonly reported categories for tissue unsuitability were compared between diabetic and nondiabetic donors. These categories are as follows:
1. Positive serology for a communicable disease (eg, syphilis, HIV, hepatitis C, etc) 2. Abnormality of the corneal endothelium (eg, ECD less than 1700 cells/mm 2 or other endothelial abnormalities) 3. Other corneal abnormalities excluding endothelial findings (eg, stromal scar, infiltrate, foreign body, etc). SAS v9.3 (SAS Institute Inc, Cary, NC) was used for all statistical analyses. The Mann-Whitney U test was used to compare age between diabetic and nondiabetic groups. For the outcome analysis, the unit of analysis was eyes as opposed to individuals. To take into account correlations between fellow eyes within individuals, we applied a mixedeffects linear regression model to test significance of the diabetic status on ECD while adjusting for age. Specifically, subject-specific intercepts were considered random, whereas all the other factors were considered fixed. The same mixedeffects-modeling approach was also used to test whether there was a significant interaction between diabetes and the lens status on ECD. All reported P values are 2-sided, and statistical significance was declared if a P value was less than 0.05.
RESULTS

Baseline Characteristics
Among the 33,643 donor eyes reported by the eye bank, we had 20,026 (59.6%) nondiabetic eyes and 13,617 (40.4%) diabetic eyes (Table 1) . Our study population was predominantly men in both groups, 13,076 (65.2%) and 8641 (63.4%) in the nondiabetic and diabetic groups, respectively. There were 3035 (9.0%) pseudophakic eyes, of which 2560 eyes (84.3%) were from the group aged 61 years or older. There were insufficient pseudophakic eyes in those younger than 41 years for meaningful analysis (n = 5). The overall mean age of nondiabetic donors (54.8 6 0.1 yrs) was significantly younger than that of diabetic donors (59.2 6 0.1 yrs, P , 0.001). After stratifying by age groups, the mean age of nondiabetic donors was only younger in the middleaged subset (41-60 yrs, P , 0.001).
The proportion of corneas deemed unsuitable for transplantation was higher in the diabetic group than in the nondiabetic group (39.7% vs. 37.5%, P , 0.001). Of the corneas unsuitable for transplantation, the diabetic group had a higher proportion in all 3 of the most frequently reported reasons for unsuitability: 1) positive serology for a communicable disease (23.4% vs. 20.2%, P , 0.001), 2) abnormality with the corneal endothelium (18.9% vs. 15.9%, P , 0.001), and 3) other corneal abnormalities excluding endothelial findings (14.5% vs. 8.2%, P , 0.001).
Endothelial Cell Density
The age-adjusted mean ECD was 2604 6 4 cells per square millimeter for nondiabetic donor corneas and 2576 6 5 cells per square millimeter for diabetic donor corneas (P , 0.001) ( Table 2 ). After stratifying for age, there was no difference in the age-adjusted mean ECD in the group 20 years or younger (P = 0.874). However, age-adjusted mean ECD remained significantly less in diabetic corneas in the age group between 41 and 60 years (234 cells/mm 2 , P , 0.001) and 61 years or older (230 cells/mm 2 , P , 0.001).
Among phakic donors, diabetic ECD was lower in the middle-aged subgroups, between 21 and 40 years (233 cells/mm 2 , P = 0.048) and between 41 and 60 years (225 cells/mm 2 , P = 0.009) ( Table 3 ). There was no difference in ECD for phakic corneas from the subset aged 61 years or older (P = 0.547). Among pseudophakic donors, diabetic ECD was lower in the oldest subgroup, age 61 years or older (256 cells/mm 2 , P = 0.026). Diabetic ECD did not differ significantly in the younger group of pseudophakic eyes aged between 41 and 60 years (P = 0.498).
Comparison of Endothelial Cell Loss in Pseudophakia
For both diabetic and nondiabetic donors of all age groups, pseudophakic eyes had significantly lower ageadjusted mean ECD than phakic eyes (see Table 1 , Supplemental Digital Content 1, http://links.lww.com/ICO/A474). The magnitude of difference between phakic and pseudophakic eyes was greater in diabetic donors (309 6 11 cells/ mm 2 ), compared with that in nondiabetic donors (251 6 12 cells/mm 2 , P , 0.001). When stratified by age, this interaction remained significant in the age group 61 years or older (P , 0.001) but not in the younger age group, between 41 and 60 years (P = 0.361) (see Table 2 , Supplemental Digital Content 2, http://links.lww.com/ICO/A475).
DISCUSSION
Our eye bank-based study shows that donor corneas with a history of diabetes have fewer corneal endothelial cells than those of nondiabetic donors. The statistical relationship strengthened in older age subgroups 41 years or above. Phakic diabetic corneas were most strongly affected in the middle-aged subgroup between 41 and 60 years, whereas pseudophakic corneas were most affected in the age group 61 years or older. Our observations corroborate numerous other investigations that report a decreased ECD in diabetic eyes. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] These observations are also consistent with animal-based biochemical studies implicating the deleterious effect of the activated polyol pathway 24 and oxidative stress 25 on the corneal endothelium.
In a large population-based study from rural India, 7 the age-adjusted mean ECD was 66 cells per square millimeter less in patients with type 2 diabetes than in those without diabetes, which contrasts with our 28 cells per square millimeter difference for our entire population. Their study included only phakic patients with type 2 diabetes, most of whom (69.5%) fell between 40 and 60 years of age, whereas our study included considerably more heterogeneity in age and diabetic and phakic status.
Interestingly, diabetes did not exert an effect on the ageadjusted mean ECD in the phakic subgroup analysis, aged 61 years or more. Factors and patterns leading to donor expiration could explain this effect. Although the mean age between patients with diabetes and without diabetes was similar in the subgroup aged 61 years or more, the mean age of patients with diabetes in the subgroup between 41 and 60 years was significantly younger than similarly aged patients without diabetes (Table 1) . This points to a fundamental difference between the 2 subgroups: the patients with diabetes in the younger age group were dying at a younger age, whereas the patients with diabetes in the older age group were better able to survive their disease into later years. This may reflect differences in the medical history (eg, type 1 vs. type 2 diabetes), disease severity, or socioeconomic status, which have a significant impact on mortality. 26 We acknowledge that there may be a significant portion of undiagnosed diabetes in our control group because nearly 30% of diabetes mellitus remains undiagnosed in the American population. 27 Collection of data on hemoglobin A1c and serologic screening of donors is not included in the standard protocol for tissue harvest at the Lions Eye Institute and thus those data are unavailable for our study. Presumably, patients with undiagnosed diabetes would have milder or early manifestations of disease and would thus have an ECD similar to that of a nondiabetic individual. If these individuals with undiagnosed diabetes were moved to the diabetic group, it is possible that the difference in ECD between groups would be further diluted. However, our eye bank data are representative of information available to the corneal surgeon and would still remain clinically applicable in setting the surgeon's expectation of ECD in patients with diabetes.
Our proportion of diabetic donors (40%) is higher than that reported in the literature. The Cornea Donor Study (CDS) and the Cornea Preservation Time Study had a lower number of diabetic donors (18% and 27%, respectively) because both prospective studies followed grafts that were suitable for transplantation and were thus biased to exclude corneas unsuitable for transplantation. 28, 29 The question in our study is fundamentally different from that in the CDS and the Cornea Preservation Time Study, because we chose to include all corneas, even those unsuitable for transplantation, to study the overall effect of diabetes on ECD.
Many studies have shown that the duration and severity of diabetes has an adverse effect on ECD. 4, 5, [8] [9] [10] [11] 15, 17 Furthermore, patients with type 1 diabetes are believed to experience accelerated loss of ECD compared with patients with type 2 diabetes. 13, 16 Unfortunately, our study was not equipped to validate these observations as these details of the medical history are not gathered as part of the eye bank's protocol. These data may become increasingly relevant to eye banks as our understanding of the effect of diabetes on the cornea continues to evolve.
Our data suggest that the corneal endothelium suffers greater attrition after cataract surgery in patients with diabetes when compared with patients without diabetes of a similar age. This is consistent with other reports that suggest increased vulnerability of the corneal endothelium to cataract surgery. [19] [20] [21] Although this relationship was significant in the oldest age subgroup 61 years or older, it did not differ significantly in the middle-aged subgroup between 41 and 60 years. This effect could reflect resilience to surgical stress enjoyed by a younger corneal endothelium, or alternatively, reflect increased susceptibility to damage in older patients with diabetes. We do recommend restraint when interpreting this finding, as neither preoperative ECD nor intraoperative phacoemulsification settings were available for our studyboth variables have been known to the outcome of postoperative ECD. 23 Our database shows that diabetic donors have a higher proportion of tissue that is graded unsuitable for transplantation than nondiabetic tissue. This finding is not entirely surprising as the presence of diabetes mellitus may serve as a surrogate marker of poor overall health status, leading to an unfavorable grade for transplantation. However, we recommend a cautious interpretation of this result because our database does not fully encompass all variables necessary to judge suitability for tissue transplantation (eg, pachymetry, pleomorphism, polymegathism, etc). Furthermore, the most frequently reported reason for unsuitability (positive serology for communicable disease) has no known association with diabetic pathophysiology. Our study expands on the previously known relationship between diabetes and ECD-the broader question of whether diabetes has an impact on graft suitability lies beyond the scope of our investigation.
The impact of the donor diabetic status on corneal transplantation is probably minimal. Two separate studies arising from the CDS showed that a history of diabetes neither the donor nor recipient increased the graft failure rate for penetrating keratoplasty. 28, 30 A study looking at both Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty showed no difference in graft failure when using tissue from donors with a history of diabetes. 31 However, 2 longitudinal studies on penetrating keratoplasty did find a higher risk of graft failure in recipients with a history of diabetes. 32, 33 Our study suggests that diabetic donors have fewer corneal endothelial cells, but this may not necessarily correlate with a higher risk of transplant failure.
In summary, we show that donors with a history of diabetes have an age-adjusted ECD that is 28 cells per square millimeter fewer than donors without diabetes. This difference rose to 56 cells per square millimeter when comparing pseudophakic donors with and without diabetes aged 61 years or older, suggesting increased vulnerability to cataract surgery. We emphasize that although statistically significant and consistent with our pathophysiologic understanding of diabetic changes in the corneal endothelium, these overall differences in ECD are small and probably do not have an impact on the overall corneal endothelial function.
